The latest bump in his fortune comes on the heels of previous gains between Feb. 12 and March 24, when his stake …
Aspen Pharmacare
-
-
This rise in Saad’s stake underscores his pivotal role in South Africa’s business landscape, placing him among the top investors on the …
-
Aspen anticipates a robust second half of 2024, supported by the launch of sterile manufacturing contracts and continued growth in its active …
- Hot News
South African tycoon Gus Attridge’s stake in Africa’s biggest pharma company hits $215 million
Attridge’s recent financial triumph is attributed to the recent surge in Aspen Pharmacare’s shares on the Johannesburg Stock Exchange (JSE).
-
This increase cements Saad’s position in the South African business scene, placing him among the leading investors on the JSE.
-
According to data compiled by Billionaires.Africa, the market value of Saad’s stake in Aspen has increased by $52.4 million to $623.6 million.
-
Attridge, Aspen’s group chief advisor who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding …
-
Attridge, Aspen’s group chief advisor who ranks as one of JSE’s richest investors, owns a 4.26-percent stake in the pharma group.
-
The upswing comes on the heels of a setback that led to Attridge recording a loss of $11.96 million between Oct. 2 …
-
At the helm of Aspen Pharmacare, Attridge has made significant contributions to Africa’s healthcare sector.